SG11202111116VA - Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereof - Google Patents
Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereofInfo
- Publication number
- SG11202111116VA SG11202111116VA SG11202111116VA SG11202111116VA SG11202111116VA SG 11202111116V A SG11202111116V A SG 11202111116VA SG 11202111116V A SG11202111116V A SG 11202111116VA SG 11202111116V A SG11202111116V A SG 11202111116VA SG 11202111116V A SG11202111116V A SG 11202111116VA
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- application
- method therefor
- composition
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910278955.6A CN111803632B (zh) | 2019-04-09 | 2019-04-09 | 黄酮多酚类药物自乳化组合物、其制备方法、药物组合物及用途 |
PCT/CN2020/083837 WO2020207417A1 (zh) | 2019-04-09 | 2020-04-08 | 黄酮多酚类药物自乳化组合物、其制备方法、药物组合物及用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202111116VA true SG11202111116VA (en) | 2021-11-29 |
Family
ID=72750939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202111116VA SG11202111116VA (en) | 2019-04-09 | 2020-04-08 | Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereof |
Country Status (11)
Country | Link |
---|---|
US (1) | US11771660B2 (es) |
EP (1) | EP3954380A4 (es) |
JP (1) | JP2022530752A (es) |
KR (1) | KR102497718B1 (es) |
CN (2) | CN111803632B (es) |
AU (1) | AU2020256609B2 (es) |
CA (1) | CA3132454C (es) |
MX (1) | MX2021012268A (es) |
SG (1) | SG11202111116VA (es) |
WO (1) | WO2020207417A1 (es) |
ZA (1) | ZA202108771B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112773787A (zh) * | 2021-01-17 | 2021-05-11 | 卢奕 | 一种黄酮多酚类药物自乳化组合物 |
CN115252802A (zh) * | 2021-04-29 | 2022-11-01 | 苏州裕泰医药科技有限公司 | 多西他赛-硬脂酸甘油三酯前药及其脂质制剂的制备 |
CN115252801A (zh) * | 2021-04-29 | 2022-11-01 | 苏州裕泰医药科技有限公司 | 多西他赛-油酸甘油三酯前药及脂质制剂的制备 |
CN113350515B (zh) * | 2021-05-31 | 2023-03-17 | 浙江中医药大学 | 一种漆黄素磷脂复合物及其制备方法和应用 |
CN113925862A (zh) * | 2021-12-17 | 2022-01-14 | 北京五和博澳药业股份有限公司 | 一种预防和/或治疗炎症风暴的药物组合物及其制剂与应用 |
CN114712311B (zh) * | 2022-04-15 | 2023-05-23 | 青岛科技大学 | 一种丝素蛋白肽自组装载药纳米粒的制备及其肾保护作用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696484B2 (en) | 1997-10-31 | 2004-02-24 | University Of Chicago Office Of Technology And Intellectual Property | Method and compositions for regulation of 5-alpha reductase activity |
DE60328676D1 (de) | 2002-04-30 | 2009-09-17 | Unigen Pharmaceuticals Inc | Formulierung eines gemisches aus flavonoiden und flavanen mit freiem b ring als therapeutisches mittel |
BRPI0707584A2 (pt) | 2006-02-09 | 2011-05-10 | Merck & Co Inc | composiÇço farmacÊutica, uso da composiÇço farmacÊutica, e, formulaÇço farmacÊutica |
EP1837030A1 (en) * | 2006-03-09 | 2007-09-26 | INDENA S.p.A. | Phospholipid complexes of curcumin having improved bioavailability |
CN101088524B (zh) * | 2006-06-12 | 2013-01-02 | 北京五和博澳医药科技发展有限公司 | 黄芩天然活性成分的磷脂复合物及其制备方法和制剂 |
JP5358574B2 (ja) | 2007-08-17 | 2013-12-04 | アルション セラピューティクス, インコーポレイテッド | 高濃度の局所麻酔薬調合物 |
GB0807605D0 (en) | 2008-04-28 | 2008-06-04 | Diurnal Ltd | Lipid composition |
EP2229940B1 (en) * | 2009-03-20 | 2015-07-01 | Bioxtract S.A. | Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties |
CN101579291B (zh) * | 2009-05-20 | 2011-06-15 | 清华大学 | 一种白藜芦醇磷脂复合物纳米乳液及其制备方法与应用 |
CN101704838A (zh) * | 2009-11-30 | 2010-05-12 | 浙江大学 | 一种黄芩素磷脂复合物及其制备方法 |
US8835509B2 (en) * | 2010-05-31 | 2014-09-16 | Arbro Pharmaceuticals Ltd. | Self emulsifying drug delivery system for a curcuminoid based composition |
US20140271867A1 (en) | 2013-03-15 | 2014-09-18 | Monosol Rx, Llc | Film delivery system for active ingredients |
KR20130089414A (ko) * | 2012-02-02 | 2013-08-12 | 순천향대학교 산학협력단 | 바이칼린의 자가미세유화시스템 제제화 방법 |
CN103083683B (zh) * | 2013-02-05 | 2015-02-11 | 广东华南药业集团有限公司 | 一种灯盏花素磷脂复合物及其制备方法和应用 |
CN103169657A (zh) * | 2013-03-06 | 2013-06-26 | 华中科技大学 | 一种含灯盏花素磷脂复合物的自乳化剂及其制备方法和用途 |
CN103877149A (zh) * | 2014-03-18 | 2014-06-25 | 新疆维吾尔自治区药物研究所 | 香青兰总黄酮磷脂复合物、香青兰总黄酮磷脂复合物自乳化剂及其制备方法 |
CN104382888B (zh) * | 2014-11-06 | 2017-02-15 | 江苏隆力奇生物科技股份有限公司 | 一种白藜芦醇磷脂复合物自微乳颗粒的制备方法 |
US20170281573A1 (en) * | 2016-03-31 | 2017-10-05 | Pharcon Inc. | Medicinal composition for enhanced delivery of triterpenes |
CN107308132B (zh) | 2016-04-26 | 2021-08-17 | 北京五和博澳药业股份有限公司 | 一种磷脂壳聚糖药物递送系统及其制备方法和用途 |
CN107308133A (zh) * | 2016-04-27 | 2017-11-03 | 周意 | 姜黄素药物制剂 |
CN107007569B (zh) * | 2017-03-23 | 2019-08-30 | 徐州医科大学 | 一种载槲皮素和白藜芦醇的磁性脂质纳米粒及其制备方法 |
-
2019
- 2019-04-09 CN CN201910278955.6A patent/CN111803632B/zh active Active
- 2019-04-09 CN CN202210398779.1A patent/CN114617968B/zh active Active
-
2020
- 2020-04-08 AU AU2020256609A patent/AU2020256609B2/en active Active
- 2020-04-08 EP EP20787816.6A patent/EP3954380A4/en active Pending
- 2020-04-08 KR KR1020217036618A patent/KR102497718B1/ko active IP Right Grant
- 2020-04-08 CA CA3132454A patent/CA3132454C/en active Active
- 2020-04-08 WO PCT/CN2020/083837 patent/WO2020207417A1/zh unknown
- 2020-04-08 US US17/602,423 patent/US11771660B2/en active Active
- 2020-04-08 JP JP2021560466A patent/JP2022530752A/ja active Pending
- 2020-04-08 MX MX2021012268A patent/MX2021012268A/es unknown
- 2020-04-08 SG SG11202111116VA patent/SG11202111116VA/en unknown
-
2021
- 2021-11-08 ZA ZA2021/08771A patent/ZA202108771B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2020256609A1 (en) | 2021-11-11 |
CA3132454C (en) | 2023-11-07 |
CN111803632B (zh) | 2022-04-29 |
CN114617968A (zh) | 2022-06-14 |
EP3954380A4 (en) | 2023-01-11 |
CA3132454A1 (en) | 2020-10-15 |
KR20210149829A (ko) | 2021-12-09 |
JP2022530752A (ja) | 2022-07-01 |
MX2021012268A (es) | 2022-01-04 |
CN114617968B (zh) | 2023-10-03 |
BR112021020359A2 (pt) | 2021-12-07 |
AU2020256609B2 (en) | 2023-09-28 |
ZA202108771B (en) | 2022-09-28 |
KR102497718B1 (ko) | 2023-02-17 |
US11771660B2 (en) | 2023-10-03 |
EP3954380A1 (en) | 2022-02-16 |
US20220168237A1 (en) | 2022-06-02 |
WO2020207417A1 (zh) | 2020-10-15 |
CN111803632A (zh) | 2020-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202108771B (en) | Flavonoid polyphenol drug self-emulsifying composition, preparation method therefor, pharmaceutical composition thereof and application thereof | |
SG11202105850YA (en) | Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof | |
SG11202005962YA (en) | Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application | |
IL286471B1 (en) | The history of phenylisoxazolidine (pyridine-amino-phenyl)-acrylamide, a method for their preparation and a pharmaceutical preparation containing them | |
EP3556371A4 (en) | PHARMACEUTICAL COMPOSITION BASED ON SULPHONYLURIDES AND ITS PREPARATION PROCESS | |
EP3357491A4 (en) | PHARMACEUTICAL COMPOSITION WITH ANIONIC ACTIVE SUBSTANCE AND MANUFACTURING METHOD THEREFOR | |
EP3714887A4 (en) | PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION AND RELATED PREPARATION PROCESS | |
EP4056571A4 (en) | TRICYCLIC DIHYDROIMIDAZOPYRIMIDONE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
IL276244A (en) | A pharmaceutical preparation for the eyes, a method for its preparation and its application | |
IL285421A (en) | History of indazolyl-isoxazole, their preparation and pharmaceutical preparations containing them | |
EP3858846A4 (en) | NUCLEIC ACID NANO-CARRIER MEDICINE, METHOD FOR PREPARING IT, PHARMACEUTICAL COMPOSITION THEREOF, AND CORRESPONDING USE | |
EP3450450A4 (en) | VANCOMYCINE DERIVATIVE PRODUCTION, PREPARATION, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
EP3760191A4 (en) | PHARMACEUTICAL COMPOSITION, PROCESS FOR PREPARATION AND USE OF THE LATTER | |
EP4053152A4 (en) | KERATIN BD-13, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
EP4053154A4 (en) | KERATIN BD-10, METHOD FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITION THEREOF, AND ITS USE | |
EP3308801A4 (en) | ANTIBODY-MEDICINAL CONJUGATE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
EP3616685A4 (en) | PROCESS FOR DETERMINING THE AUTHENTICITY OF A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, AND SYSTEM FOR DETERMINING THE AUTHENTICITY OF A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
EP3360561A4 (en) | Method for preparing herbal composition having increased fat-soluble polyphenol content, herbal composition prepared thereby and use thereof | |
EP4071170A4 (en) | PHARMACEUTICAL COMPOSITION, ITS PREPARATION METHOD AND ITS USE | |
EP4053151A4 (en) | KERATIN BD-1, PREPARATION METHOD, AS WELL AS PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
EP3813842A4 (en) | PHARMACEUTICAL COMPOSITION AND MANUFACTURING PROCESS THEREOF | |
EP3926047A4 (en) | NUCLEIC ACID NANO-BEARING MEDICINE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | |
EP4243808A4 (en) | CANNABINOIDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF | |
EP4137124A4 (en) | SOLID PHARMACEUTICAL PREPARATION, ITS PREPARATION METHOD AND ITS USE | |
EP4074304A4 (en) | PHARMACEUTICAL COMPOSITION OF FULVESTRANT, PREPARATION METHOD AND APPLICATION THEREOF |